- Home
- MED vs GNFT Comparison
MED vs GNFT Comparison
Compare MED & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- GNFT
- Stock Information
- Founded
- MED 1980
- GNFT 1999
- Country
- MED United States
- GNFT France
- Employees
- MED N/A
- GNFT N/A
- Industry
- MED Packaged Foods
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MED Consumer Staples
- GNFT Health Care
- Exchange
- MED Nasdaq
- GNFT Nasdaq
- Market Cap
- MED 152.3M
- GNFT 186.3M
- IPO Year
- MED N/A
- GNFT 2019
- Fundamental
- Price
- MED $14.39
- GNFT $3.83
- Analyst Decision
- MED Hold
- GNFT Strong Buy
- Analyst Count
- MED 1
- GNFT 1
- Target Price
- MED $16.50
- GNFT $13.00
- AVG Volume (30 Days)
- MED 247.1K
- GNFT 4.0K
- Earning Date
- MED 08-04-2025
- GNFT 04-24-2025
- Dividend Yield
- MED N/A
- GNFT N/A
- EPS Growth
- MED N/A
- GNFT N/A
- EPS
- MED N/A
- GNFT 0.03
- Revenue
- MED $543,452,000.00
- GNFT $73,187,701.00
- Revenue This Year
- MED N/A
- GNFT $15.98
- Revenue Next Year
- MED N/A
- GNFT N/A
- P/E Ratio
- MED N/A
- GNFT $121.41
- Revenue Growth
- MED N/A
- GNFT 105.01
- 52 Week Low
- MED $11.57
- GNFT $2.55
- 52 Week High
- MED $22.66
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- MED 62.71
- GNFT 41.57
- Support Level
- MED $14.23
- GNFT $3.44
- Resistance Level
- MED $15.33
- GNFT $3.81
- Average True Range (ATR)
- MED 0.58
- GNFT 0.17
- MACD
- MED 0.14
- GNFT -0.01
- Stochastic Oscillator
- MED 87.61
- GNFT 38.18
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.